Hutch News

New Science Spotlight Articles

Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
10 NEW July 15, 2019

New Scientific Publications

Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
1 NEW Week of July 14, 2019

Molecular mechanisms of late cancer relapse

from the Chapuis lab, Clinical Research Division
Science Spotlight - October 15, 2018

Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse

A Nature Communications report explains why some Merkel cell carcinoma patients treated with immunotherapy see their cancers shrink at first but then come back.
Releases - September 24, 2018

Triple therapy for rare skin cancer shows promise in small, early-stage trial

Combo of T-cell therapy, newly FDA-approved drug and another immune booster kept cancer at bay for three of four patients with metastatic Merkel cell carcinoma
Hutch News - May 31, 2017

The rare make the most

from the Chapuis lab (Clinical Research Division)
Science Spotlight - May 15, 2017

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
Releases - December 05, 2016

Immunotherapy shows promise in preventing leukemia relapse

Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission after more than two years
Hutch News - December 05, 2016

New clues to treating deadly skin cancer

Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma
Hutch News - June 06, 2016

Tailoring immune cells to target leukemia

Promising early trial results show engineered immune cells may help buffer against cancer relapse after bone marrow transplantation
Hutch News - April 21, 2016

Good News at Fred Hutch

<p>Dr. Aude Chapuis named Damon Runyon Clinical Investigator; Dr. Jonathan Bricker receives $3.1M NCI grant to test quit-smoking smartphone app; Dr. Hans-Peter Kiem appointed chair of NIH Recombinant DNA Advisory Committee; Dr. Julie Overbaugh receives award from Association for Women in Science</p>
Hutch News - June 18, 2015
Last Modified, July 11, 2019